Investorideas.com

Get great ideas from our AI, cannabis, cleantech, crypto, esports and mining podcasts - be a guest or sponsor : 800 665 0411


Share on StockTwits

Five leading health care companies lost over $65 billion in market cap YTD

 

September 17, 2020 (Investorideas.com Newswire) Data presented by Buy Shares indicates that five selected leading public health care companies have cumulatively lost $65.59 billion in market capitalization. The slump is on a Year-to-Date basis.

Health care companies banking on coronavirus vaccine

Walgreens Boots Alliance is the biggest loser at $21.21billion. CVS Health is the second biggest loser at $20.81 billion followed by Cigna Corp at $13.88 billion.

From the research, Anthem Inc. market capitalization has plunged by $8.91 billion while Cardinal Health had the least loss at $0.78 billion.

Despite the widespread losses, UnitedHealth Group's market capitalization gained by a massive $16.73 billion. Johnson & Johnson also gained by $3.97 billion during the period under review.

Although the health care sector has registered a decline in market capitalization, several factors might spark a resurgence. According to the research report:

"The health care companies are banking on a possible vaccine to make a rebound in the market. Currently, there are over 70 vaccines under development, and companies that emerge first are likely to benefit from that. For example, Johnson & Johnson's positive change in market capitalization can be linked to the fact that the company is very active in vaccine searching. Additionally, the stock market is also depending on the vaccines to make a rebound. Positive news regarding the vaccine has seen other stocks make notable gains."

The research also overviewed the Year-to-Date returns for the selected companies. AmerisourceBergen Corp has the biggest returns at 13.84% followed by UnitedHealth Group at 4.27%. Elsewhere, Walgreens Boots Alliance has the worst returns at -38.47%. CVS Health had the second-worst returns at -22.63%.

The full story, statistics and information can be found here: https://buyshares.co.nz/2020/09/17/five-leading-health-care-companies-lost-over-65-billion-in-market-cap-ytd/


More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp


Follow Us on StockTwits






BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

Buy a biotech guest post on Investorideas.com